Sign inGet started

Cherrington Julie M

Insider CIK 1781315 · MRTX Director · ELEV Director · VXRT Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ELEV Elevation Oncology, Inc. D To issuer deriv2025-07-232025-07-2455,000— $00SEC↗
ELEV Elevation Oncology, Inc. D To issuer deriv2025-07-232025-07-2435,000— $00SEC↗
ELEV Elevation Oncology, Inc. D To issuer deriv2025-07-232025-07-2435,000— $00SEC↗
ELEV Elevation Oncology, Inc. A Award deriv2025-06-052025-06-0935,000— $035,000SEC↗
ELEV Elevation Oncology, Inc. A Award deriv2024-06-132024-06-1735,000— $035,000SEC↗
ELEV Elevation Oncology, Inc. A Award deriv2024-02-292024-03-0455,000— $055,000SEC↗
MRTX Mirati Therapeutics, Inc. D To issuer deriv2024-01-232024-01-237,520— $00SEC↗
MRTX Mirati Therapeutics, Inc. D To issuer2024-01-232024-01-234,444— $06,808SEC↗
MRTX Mirati Therapeutics, Inc. D To issuer2024-01-232024-01-236,808— $00SEC↗
MRTX Mirati Therapeutics, Inc. A Award2023-12-292024-01-036,808$58.75 $400.0K11,252SEC↗
MRTX Mirati Therapeutics, Inc. A Award deriv2023-01-202023-01-247,520— $07,520SEC↗
MRTX Mirati Therapeutics, Inc. A Award2023-01-202023-01-244,444— $04,444SEC↗
MRTX Mirati Therapeutics, Inc. S Sale2023-01-182023-01-202,546$44.66 $113.7K0SEC↗
VXRT Vaxart, Inc. A Award deriv2022-08-042022-08-0837,280— $037,280SEC↗
VXRT Vaxart, Inc. A Award2022-08-042022-08-086,217— $06,217SEC↗
MRTX Mirati Therapeutics, Inc. S Sale2022-01-192022-01-201,475$116.07 $171.2K2,546SEC↗
MRTX Mirati Therapeutics, Inc. A Award deriv2022-01-142022-01-183,688— $03,688SEC↗
MRTX Mirati Therapeutics, Inc. A Award2022-01-142022-01-182,546— $04,021SEC↗
VXRT Vaxart, Inc. A Award deriv2021-08-202021-08-2365,700— $065,700SEC↗
MRTX Mirati Therapeutics, Inc. S Sale2021-03-022021-03-0410$203.00 $2.0K1,475SEC↗
MRTX Mirati Therapeutics, Inc. S Sale2021-03-022021-03-041,990$201.00 $400.0K1,485SEC↗
MRTX Mirati Therapeutics, Inc. A Award deriv2021-01-152021-01-202,155— $02,155SEC↗
MRTX Mirati Therapeutics, Inc. A Award2021-01-152021-01-201,475— $03,475SEC↗
MRTX Mirati Therapeutics, Inc. A Award deriv2020-01-032020-01-074,000— $04,000SEC↗
MRTX Mirati Therapeutics, Inc. A Award2020-01-032020-01-072,000— $02,000SEC↗
MRTX Mirati Therapeutics, Inc. A Award deriv2019-06-272019-07-0125,000— $025,000SEC↗